PluvictoTM plus standard of care (ARPI + ADT) significantly reduced risk of progression or death by 28% (HR 0.72) versus SoC alone, with positive trend in OS (HR 0.84) in PSMA+ metastatic ...
Patients with previously untreated, locally advanced, unresectable or metastatic triple-negative breast cancer who are not ...
Flu season is here and a humidifier is one of your best defenses. Some of Levoit’s most popular options are up to 25% off ...
The FDA accepted a new drug application for a single inhaler that contains beclomethasone dipropionate, formoterol fumarate ...
ACOG has released new guidance recommending concurrent sexual partner therapy for some patients experiencing recurrent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback